Sensitivity of lysosomal enzymes to the plant alkaloid sanguinarine: Comparison with other SH-specific agents

Cell Biology International

Volumn 27, Issue 11, 2003, Pages 887-895

  Belyaeva, T ^a   Leontieva, E ^a   Shpakov, A ^b   Mozhenok, T ^a   Faddejeva, M ^a  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

^b SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

Acid phosphatase; Dithiothreitol; Lysosomes; N acetyl ,D glucosaminidase; N ethylmaleimide; p chloromercuribenzoic acid; Sanguinarine

Indexed keywords

4 CHLOROMERCURIBENZOIC ACID; ACID LIPASE; ACID PHOSPHATASE; ARYLSULFATASE; BETA GALACTOSIDASE; LYSOSOME ENZYME; N ACETYL BETA GLUCOSAMINIDASE; N ETHYLMALEIMIDE; SANGUINARINE; THIOL GROUP;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; INCUBATION TIME; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; TEMPERATURE;

EID: 0142247234     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1065-6995(03)00161-6     Document Type: Article

References (44)

1. Ahmad N., Gupta S., Husain M.M., Heiskanen K.M., Mukhtar H. Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin Cancer Res. 6:2000;1524-1528.
2. D'Azzo A., Hoogeveen A., Reuser A.J., Robinson D., Galjaard H. Molecular defect in combined β-galactosidase and neuraminidase deficiency in man. Proc Natl Acad Sci U S A. 79:1982;4535-4539.
3. Barrett A.J. Lysosomal enzymes. Assay methods. Lysosomes: a laboratory handbook. 1972;110-125 Elsevier, Amersham.
4. Belyaeva T.N., Bulychev A.G., Lasskaya O.E., Semenova E.G. Effects of sanguirytrine on the functional activity of lysosomes in fibroblasts. Cytology (Russia). 36:1990;16-18.
5. Belyaeva T.N., Faddejeva M.D. Disturbance of energy transduction in rat liver mitochondria by sanguinarine and AphMA. Cytology (Russia). 37:1995;237-248.
6. Boustany R.M., Qian W.H., Suzuki K. Mutations in acid β-galactosidase cause GM1 gangliosidosis in American patients. Am J Hum Genet. 53:1993;881-888.
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
8. Evans J., Bosmann H.B. Bromodixyuridine (BudR) treatments of melanoma cells decrease cellular proteolytic activity. Exp Cell Res. 108:1977;151-155.
9. Faddejeva M.D., Belyaeva T.N. Sanguinarine and ellipticine: cytotoxic alkaloids isolated from well-known antitumor plants. Intracellular targets of their action. Cytology (Russia). 39:1997;181-207.
10. Fernandes M.J., Yew S., Leclerc D., Henrissat B., Vorgias C.E., Gravel R.A., et al. Identification of candidate active site residues in lysosomal β-hexosaminidase A. J Biol Chem. 272:1997;814-820.
11. Hiraiwa M., Saitoh M., Arai N., Shiraishi T., Odani S., Uda Y., et al. Protective protein in the bovine lysosomal β-galactosidase complex. Biochim Biophys Acta. 1341:1997;189-199.
12. Hou Y., Vocadlo D.J., Leung A., Withers S.G., Mahuran D. Characterization of the Glu and Asp residues in the active site of human β-hexosaminidase B. Biochemistry. 40:2001;2201-2209.
13. Gomez-Lira M., Sangalli A., Mottes M., Perusi C., Pignatti P.F., Rizzuto N., et al. A common β-hexosaminidase gene mutation in adult Sandhoff disease patients. Hum Genet. 96:1995;417-422.
14. Ishii N., Oohira T., Oshima A., Sakuraba H., Endo F., Matsuda I., et al. Clinical and molecular analysis of a Japanese boy with Morquio B disease. Clin Genet. 48:1995;103-108.
15. Itoh K., Naganawa Y., Kamei S., Shimmoto M., Sakuraba H. Stabilizing effect of lysosomal β-galactosidase on the catalytic activity of protective protein/cathepsin A secreted by human platelets. Biochem Biophys Res Commun. 253:1998;228-234.
16. Keilin D., King T.E. Effect of inhibitors on the activity of soluble succinate dehydrogenase and the reconstitution of the SDH-cytochrome system from its components. Proc Natl Acad Sci U S A. 152:1960;163-187.
17. Kuroki Y., Itoh K., Nadaoka Y., Tanaka T., Sakuraba H. A novel missense mutation (C522Y) is present in the β-hexosaminidase beta-subunit gene of a Japanese patient with infantile Sandhoff disease. Biochem Biophys Res Commun. 212:1995;564-571.
18. Loeffler M., Kroemer G. The mitochondrion in cell death control: certainties and incognita. Exp Cell Res. 256:2000;19-26.
19. Lowry O.H., Roserbrough N.J., Farr A.J., Randall R.J. Protein measurement with Folin phenol reagent. J Biol Chem. 193:1951;265-275.
20. Mahuran D.J., Neote K., Klavins M.H., Leung A., Gravel R.A. Proteolytic processing of pro-α and pro-β precursors from human β-hexosaminidase. Generation of the mature α and βAβB subunits. J Biol Chem. 263:1988;4612-4618.
21. McCarter J.D., Burgoyne D.L., Miao S., Zhang S., Callahan J.W., Withers S.G. Identification of Glu-268 as the catalytic nucleophile of human lysosomal β-glactosidase precursor by mass spectrometry. J Biol Chem. 272:1997;396-400.
22. Milsom D.W., Rose F.A., Dodgson K.S. The specific assay of arylsulfatase C, a rat liver microsomal marker enzyme. Biochem J. 128:1972;331-336.
23. Morrone A., Bardelli T., Donati M.A., Giorgi M., Di Rocco R., Gatti R., et al. Identification of new mutations in six Italian patients affected by a variant form of infantile GM1-gangliosidosis with severe cardiomyopathy. Am J Hum Genet. 61:1997;A258.
24. Nishimoto J., Nanba E., Inui K., Okada S., Suzuki K. GM1-gangliosidosis (genetic β-galactosidase deficiency): identification of four mutations in different clinical phenotypes among Japanese patients. Am J Hum Genet. 49:1991;566-574.
25. Ostanin K., Saeed A., Van Etten R.L. Heterologous expression of human prostatic acid phosphatase and site-directed mutagenesis of the enzyme active site. J Biol Chem. 269:1994;8971-8978.
26. Potier M., Michaud L., Tranchemontagne J., Thauvette L. Structureof lysosomal neuraminidase - β-galactosidase - carboxypeptidase multienzymic complex. Biochem J. 267:1990;197-202.
27. Scriver R.S., Beaudet A.L., Sly W.S., Valle D. Lysosomal enzymes. The metabolic and molecular bases of inherited disease. 7th edn:1995;2425-2879 McGraw-Hill, New York (USA).
28. Semenova E.G., Khomenko A.V., Mamaeva S.E. Fluctuations in the cell cycle span and karyotype of murine L cells depending on the mode of cultivation. Cytology (Russia). 26:1984;1156-1160.
29. Silva C.M., Severini M.H., Sopelsa A., Coelho J.C., Zaha A., D'Azzo A., et al. Six novel β-galactosidase gene mutations in Brazilian patients with GM1-gangliosidosis. Hum Mutat. 13:1999;401-409.
30. Steinberg T.H. Cellular transport of drugs. Clin Infect Dis. 19:1994;916-921.
31. Suffness M., Cordell G.A. Benzo[c]phenanthridine alkaloids. The alkaloids. Chemistry and pharmacology. 25:1985;178-188 Academic Press, Orlando.
32. Tanaka A., Sakazaki H., Murakami H., Isshiki G., Suzuki K. Molecular genetics of Tay-Sachs disease in Japan. J Inherit Metab Dis. 17:1994;593-600.
33. Tulsiani D.R., Touster O. Substrate specificities of rat kidney lysosomal and cytosolic α-D-mannosidases and effects of swainsonine suggest a role of the cytosolic enzyme in glycoprotein catabolism. J Biol Chem. 262:1987;6506-6514.
34. Van Der Spoel A., Bonten E., d'Azzo A. Processing of lysosomal β-galactosidase. The C-terminal precursor fragment is an essential domain of the mature enzyme. J Biol Chem. 275:2000;10035-10040.
35. Verheijen F., Brossmer R., Galjaard H. Purification of acid β-galactosidase and acid neuraminidase from bovine testis: evidence for an enzyme complex. Biochem Biophys Res Commun. 108:1982;868-875.
36. Walterova D., Preininger V., Granbal F., Simanek V., Santavy F. Fluorescence spectra and cation-pseudobase equilibria of some benzophenanthridine alkaloids. Heterocycles. 14:1980;597-600.
37. Walterova D., Ulrichova J., Preininger V., Simanek V. Inhibition of liver alanine aminotransferase activity by benzophenanthridine alkaloids. J Med Chem. 24:1981;1100-1103.
38. Wang B.H., Lu Z.X., Polya G.M. Inhibition of eukaryotic protein kinases by isoquinoline and oxazine alkaloids. Planta Med. 63:1997;494-498.
39. Weerasinghe P., Hallock S., Tang S.C., Liepins A. Role of Bcl-2 family proteins and caspase-3 in sanguinarine-induced bimodal cell death. Cell Biol Toxicol. 17:2001a;371-381.
40. Weerasinghe P., Hallock S., Tang S.C., Liepins A. Sanguinarine induces bimodal cell death in K562 but not in high Bcl-2-expressing JM1 cells. Pathol Res Pract. 197:2001b;717-726.
41. Weerasinghe P., Hallock S., Liepins A. Bax, Bcl-2, and NF-kappaB expression in sanguinarine induced bimodal cell death. Exp Mol Pathol. 71:2001c;89-98.
42. Wolff J., Knipling L. Antimicrotubule properties of benzophenanthridine alkaloids. Biochemistry. 32:1993;13334-13339.
43. Yamada H., Hayashi H., Natori Y. Simple procedure for the isolation of highly purified lysosomes from normal rat liver. J Biochem. 95:1984;1155-1160.
44. Yoshida K., Oshima A., Shimmoto M., Fukuhara Y., Sakuraba H., Yanagisawa N., et al. Human β-galactosidase gene mutations in GM1-gangliosidosis: a common mutation among Japanese adult/chronic cases. Am J Hum Genet. 49:1991;435-442.